Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly high » significantly higher (Expand Search), significantly change (Expand Search), significantly larger (Expand Search)
significantly less » significantly lower (Expand Search), significantly reduce (Expand Search), significantly better (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly high » significantly higher (Expand Search), significantly change (Expand Search), significantly larger (Expand Search)
significantly less » significantly lower (Expand Search), significantly reduce (Expand Search), significantly better (Expand Search)
-
1501
(a) Comparison of the approximate solution X(x,y) with the exact solution of the problem 3.
Published 2025Subjects: -
1502
Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2022.
Published 2025Subjects: -
1503
Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA.
Published 2025Subjects: -
1504
-
1505
Fixed-effects panel regression results for nicotine dependence drug prescribing.
Published 2025Subjects: -
1506
-
1507
Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2021.
Published 2025Subjects: -
1508
(a) Absolute error of the example 3, X(x,y) for scale level ranging from 2 to 7.
Published 2025Subjects: -
1509
-
1510
-
1511
Drugs used in nicotine dependence (N07BA) prescribing changes from 2014 to 2022.
Published 2025Subjects: -
1512
-
1513
Scatterplots of N07BA (nicotine dependence drugs) patient differences by regions – the year 2020.
Published 2025Subjects: -
1514
Drugs used in opioid dependence (N07BC) prescribing changes from 2014 to 2022.
Published 2025Subjects: -
1515
-
1516
(A) NPRC was highly expressed in WT podocytes compared to either NPRA or NPRB in the presence of absence of NPRC KD.
Published 2025“…<p>In addition, NPRC KD effectively decreased NPRC mRNA in cultured podocytes. (B) NPRB expression was downregulated in NPRC KD cells. …”
-
1517
<sup>177</sup>Lu-Labeled Heterodimeric Agent with High Stability Targeting Neovascularization for Tumor Radioligand Therapy
Published 2025“…Radiopharmaceutical theranostics holds significant promise in tumor diagnosis and treatment, but suboptimal tumor uptake and retention remain a persistent limitation. …”
-
1518
-
1519
-
1520